Institutional Ownership Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX). We have compiled data on the 30 institutions that hold shares in the stock, with a total of 2.69 Million shares, which have been reported (via 13F filing form) to have a value of $7.19 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
David Einhorn
Greenlight Capital Inc | New York, Ny
|
Feb 14, 2024 Q4 2023 |
588,410
shares
|
$1.57 Million
0.1% of portfolio
|
Q4 2023
Added 7.66%
|
|
|
Dme Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
566,130
shares
|
$1.51 Million
0.06% of portfolio
|
Q1 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
267,421
shares
|
$714,014
0.0% of portfolio
|
Q4 2024
Reduced 1.67%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
177,075
shares
|
$472,790
0.0% of portfolio
|
Q4 2024
Added 21.94%
|
|
|
Joel Greenblatt
Gotham Asset Management, LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
158,155
shares
|
$422,273
0.0% of portfolio
|
Q4 2024
Reduced 52.73%
|
|
|
Telemetry Investments, L.L.C.
New York, NY |
Feb 14, 2023 Q4 2022 |
123,000
shares
|
$328,410
0.61% of portfolio
|
Q4 2022
Reduced 18.0%
|
|
|
Jones Financial Companies Lllp
|
Feb 05, 2025 Q4 2024 |
98,250
shares
|
$262,327
0.0% of portfolio
|
Q4 2024
Added 83.64%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
91,738
shares
|
$244,940
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
88,512
shares
|
$236,327
0.0% of portfolio
|
Q4 2024
Added 1744.0%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
84,620
shares
|
$225,935
0.0% of portfolio
|
Q2 2024
Added 12.23%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
84,586
shares
|
$225,844
0.0% of portfolio
|
Q4 2024
Added 88.2%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
71,137
shares
|
$189,935
0.0% of portfolio
|
Q4 2024
Added 106.57%
|
|
|
Cambridge Investment Research Advisors, Inc.
|
Feb 14, 2025 Q4 2024 |
54,500
shares
|
$145,515
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
46,913
shares
|
$125,257
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Prelude Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
35,820
shares
|
$95,639
0.0% of portfolio
|
Q1 2024
Reduced 38.35%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
35,227
shares
|
$94,056
0.0% of portfolio
|
Q4 2024
Added 316.64%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
30,004
shares
|
$80,110
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
17,500
shares
|
$46,725
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Benedict Financial Advisors Inc
|
Jan 28, 2025 Q4 2024 |
16,000
shares
|
$42,720
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Sandhill Capital Partners LLC
Buffalo, NY |
Feb 13, 2025 Q4 2024 |
15,400
shares
|
$41,118
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Sprott Inc.
Toronto, A6 |
Feb 04, 2025 Q4 2024 |
14,000
shares
|
$37,380
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
11,612
shares
|
$31,004
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Creekmur Asset Management LLC
Morton, IL |
Feb 12, 2025 Q4 2024 |
4,440
shares
|
$11,854
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Mai Capital Management
|
Feb 14, 2025 Q4 2024 |
4,410
shares
|
$11,774
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
4,085
shares
|
$10,906
0.0% of portfolio
|
Q4 2024
Added 13.98%
|